SEC Form 4 · accession 0001209191-17-015460
ANAPTYSBIO, INC · ANAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Lydon
Director
Period of report
Feb 24, 2017
Accepted (ET)
Feb 28, 2017 · 6:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001370053
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $24.60 | Feb 24, 2017 | A | 15,000 | A | — | Feb 23, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The stock option vests and becomes fully exercisable on February 24, 2018.